Lanoxin

Teva’s third strike at the Japanese generic market, the new favorite of drug makers

Last fortnight, Japan dominated the pharmaceutical deal making scenario, giving us the much needed

How little-known Lannett may soon become a billion-dollar generic company?

In August, when Fortune magazine published its latest ranking of the fastest-growing companies in t

Plan an African safari to discover the world’s fastest growing pharmaceutical opportunity

Africa represents the last geographic frontier where high growth is still achievable. Over the past

With a $1.2 billion buy, Concordia re-affirms that old drugs are indeed gold!

Canada based, Concordia Healthcare continued their buying spree of old, established drug brands

FDA Strikes More Than 40 Drugs Approvals In 2014

Unless you are like Voltaire and think that “The art of medicine consists of amusing patients